TY - JOUR
T1 - Interleukin-1 regulates interleukin-6 secretion in human oral squamous cell carcinoma in vitro
T2 - Possible influence of p53 but not human papillomavirus E6/E7
AU - Woods, Kendra V.
AU - Adler-Storthz, Karen
AU - Clayman, Gary L.
AU - Francis, Gail M.
AU - Grimm, Elizabeth A.
PY - 1998/7/15
Y1 - 1998/7/15
N2 - We have previously shown that interleukin-1 (IL-1) and IL-6 are constitutively produced by human oral squamous cell carcinoma (SCC) and some derived cell lines but not by cultured normal oral keratinocytes. To elucidate possible cytokine regulatory pathways that may contribute to oral SCC growth and/or progression, we tested the hypotheses that exogenous and/or endogenous IL-1 regulates IL-6 production in vitro. We investigated the effects of exogenous IL-1 and IL-6 on secondary cytokine secretion. Our studies revealed that IL-1 strongly up-regulated IL-6 protein secretion in all three cell lines tested. This effect was completely abrogated by IL-1 receptor antagonist. IL-1 receptor antagonist also inhibited the secretion of IL-1α and IL-1β in two of three cell lines. These data show for the first time that IL-1 strongly up-regulates IL-6 and support the notion of autocrine regulation of IL-1 in certain oral SCC cell lines. Additionally, because human papillomavirus (HPV) infection and p53 mutation have been implicated in the malignant transformation of SCC, we explored a second hypothesis, that HPV and/or p53 mutation contribute to cytokine disregulation. We investigated HPV DNA presence, transcriptional activation of HPV E6/E7 (in HPV DNA- positive cell lines), and p53 gene status in our cell lines. No association between HPV DNA and cytokine expression was found. However, the oral SCC cell lines secreting the most IL-6 had mutant rather than wild-type p53.
AB - We have previously shown that interleukin-1 (IL-1) and IL-6 are constitutively produced by human oral squamous cell carcinoma (SCC) and some derived cell lines but not by cultured normal oral keratinocytes. To elucidate possible cytokine regulatory pathways that may contribute to oral SCC growth and/or progression, we tested the hypotheses that exogenous and/or endogenous IL-1 regulates IL-6 production in vitro. We investigated the effects of exogenous IL-1 and IL-6 on secondary cytokine secretion. Our studies revealed that IL-1 strongly up-regulated IL-6 protein secretion in all three cell lines tested. This effect was completely abrogated by IL-1 receptor antagonist. IL-1 receptor antagonist also inhibited the secretion of IL-1α and IL-1β in two of three cell lines. These data show for the first time that IL-1 strongly up-regulates IL-6 and support the notion of autocrine regulation of IL-1 in certain oral SCC cell lines. Additionally, because human papillomavirus (HPV) infection and p53 mutation have been implicated in the malignant transformation of SCC, we explored a second hypothesis, that HPV and/or p53 mutation contribute to cytokine disregulation. We investigated HPV DNA presence, transcriptional activation of HPV E6/E7 (in HPV DNA- positive cell lines), and p53 gene status in our cell lines. No association between HPV DNA and cytokine expression was found. However, the oral SCC cell lines secreting the most IL-6 had mutant rather than wild-type p53.
UR - http://www.scopus.com/inward/record.url?scp=0032527903&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032527903&partnerID=8YFLogxK
M3 - Article
C2 - 9679982
AN - SCOPUS:0032527903
SN - 0008-5472
VL - 58
SP - 3142
EP - 3149
JO - Cancer Research
JF - Cancer Research
IS - 14
ER -